奥翔药业(603229.SH)：累计回购520.12万股公司股份

Core Viewpoint - Aoxiang Pharmaceutical (603229.SH) has announced a share buyback program, indicating a strategic move to enhance shareholder value through repurchasing shares in the market [1] Summary by Categories Share Buyback Details - As of October 31, 2025, the company has repurchased a total of 5.2012 million shares [1] - The repurchased shares account for 0.63% of the company's total share capital [1] - The highest transaction price for the repurchased shares was 11.39 yuan per share, while the lowest was 7.52 yuan per share [1] - The total amount spent on the buyback, excluding transaction fees, is 50.006 million yuan [1]